David Greenwood

David Greenwood's AcademicInfluence.com Rankings

David Greenwood

Biology

#14154

World Rank

#17836

Historical Rank

Microbiology

#899

World Rank

#989

Historical Rank

biology Degrees

Download Badge

Biology

David Greenwood's Degrees

PhD Microbiology University of Manchester
Masters Medical Microbiology University of Manchester
Bachelors Biomedical Sciences University of Manchester

Why Is David Greenwood Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Greenwood's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. (1987) (156)
Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. (1995) (118)
In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. (1981) (111)
Microbiological properties of teicoplanin. (1988) (84)
Comparison of the Responses of Escherichia coli and Proteus mirabilis to Seven β-Lactam Antibiotics (1973) (82)
The quinine connection. (1992) (80)
FL 1060: a new beta-lactam antibiotic with novel properties (1973) (65)
The response of Escherichia coli to ciprofloxacin and norfloxacin. (1987) (62)
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis (1995) (55)
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency (1980) (45)
An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis. (1993) (44)
Antibiotic-induced surface changes in microorganisms demonstrated by scanning electron microscopy. (1969) (44)
An in vitro model of the urinary bladder. (1978) (42)
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. (1987) (40)
Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. (1976) (39)
A twelve channel bacterial growth monitoring system. (1973) (38)
Trimodal Response of Escherichia coli and Proteus mirabilis to Penicillins (1970) (37)
In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. (1993) (36)
Scanning electron microscopy of Staphyloccus aureus exposed to some common anti-staphylococcal agents. (1972) (36)
Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin. (1989) (32)
A comparison of the effects of ampicillin on Escherichia coli and proteus mirabilis. (1969) (32)
Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids (1978) (31)
Characterization of β-lactamases in clinical isolates of Bacteroides (1986) (31)
Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. (1973) (31)
Antibiotic resistance in enterococci. (1989) (30)
A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. (1987) (29)
The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins. (1972) (29)
Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. (1999) (29)
An investigation of β-lactamases from clinical isolates of Bacteroides species (1992) (29)
The two sites of penicillin action in Escherichia coli. (1973) (27)
Antibacterial Agents: Basis of Action (2001) (27)
Resistance to antimicrobial agents: a personal view. (1998) (27)
In Vitro Model Simulating the Form of Exposure of Bacteria to Antimicrobial Drugs Encountered in Infection (1979) (26)
Deadly Companions: How Microbes Shaped our History (2008) (26)
In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin (1981) (25)
Phenotypic resistance to antimicrobial agents. (1985) (23)
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. (1986) (23)
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis (2021) (23)
Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. (1996) (22)
The activity of polymyxins against dense populations of Escherichia coli. (1975) (21)
The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin. (1983) (21)
The trometamol salt of fosfomycin: microbiological evaluation. (1987) (21)
Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases. (1976) (21)
Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. (1976) (21)
A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics. (1982) (20)
Dual-Action Cephalosporin Utilizing a Novel Therapeutic Principle (1976) (19)
Comparative growth of Bacteroides species in various anaerobic culture media. (1985) (18)
Potent Combinations of β-Lactam Antibiotics using the β-Lactamase Inhibition Principle (1975) (18)
Factors influencing the activity of the trometamol salt of fosfomycin (1986) (18)
Detection of penicillin tolerance in streptococci. (1983) (18)
An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor. (1979) (17)
Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli (1992) (17)
Antimicrobial Drugs: Chronicle of a twentieth century medical triumph (2008) (17)
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid. (1985) (16)
Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants of Streptococcus sanguis II. (1990) (15)
An in-vitro model simulating the hydrokinetic aspects of the treatment of bacterial cystitis. (1985) (15)
Comparative antipseudomonal activity of some newer beta-lactam agents (1982) (15)
Fosfomycin trometamol: Activity in vitro against urinary tract pathogens (2005) (15)
The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. (1984) (14)
Activity of FL 1060, a new β-lactam antibiotic, against urinary tract pathogens (1974) (14)
Is your dosage really necessary? Antibiotic dosage in urinary infection. (1977) (14)
Interactions between fusidic acid and penicillins. (1973) (14)
Factors Governing the Emergence of Resistance to Nalidixic Acid in Treatment of Urinary Tract Infection (1977) (14)
The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. (1974) (13)
In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties. (1982) (13)
Effect of Osmolality on the Response of Escherichia coli to Mecillinam (1976) (13)
Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria (1981) (13)
Resistance Categories of Enterobacteria to β-Lactam Antibiotics (1975) (13)
Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis (1986) (12)
Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder. (1975) (12)
Relevance of in vitro synergy to therapy: does synergy between diaminopyrimidines and sulphonamides operate at concentrations achievable in urine? (1979) (12)
The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate (1981) (12)
The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin. (1988) (11)
Current Chemotherapy (1978) (11)
Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria. (1977) (10)
Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. (1978) (10)
Antibiotics of the beta-lactam group. (1982) (10)
Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. (1973) (9)
Detection of antibiotic resistance in vitro. (2000) (9)
The response of Staphylococcus aureus to benzylpenicillin. (1979) (9)
Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder. (1976) (9)
Differential Effects of Benzylpenicillin and Ampicillin on Escherichia coli and Proteus mirabilis in Conditions Simulating Those of the Urinary Bladder (1970) (9)
An Overview of the Response of Bacteria to β-Lactam Antibiotics (1986) (9)
Isoelectric focusing of beta-lactamases on cellulose acetate membranes. (1983) (9)
Comparative Antipseudomonal Activity of Some Newer Lactam Agents (9)
Activity of Cefazolin Against Dense Populations of Enterobacteria (1975) (9)
Fosfomycin trometamol and the single-dose treatment of cystitis. (1994) (9)
Lysis enhancement: a novel form of interaction between beta-lactam antibiotics. (1975) (8)
Activity of teicoplanin against gram-negative anaerobes. (1988) (8)
Tarnished gold: sixty years of antimicrobial drug use and misuse. (1995) (8)
Distinctive outer membrane protein and lipopolysaccharide composition of Bacteroides fragilis strains that produce metallo-beta-lactamase. (1997) (8)
Fixed or variable concentrations of βlactamase inhibitors in in-vitro tests? (1996) (8)
Comparative activity of LY146032 against anaerobic cocci (1987) (8)
Tolerance to penicillin in streptococci of viridans group. (1989) (7)
An investigation of beta-lactamases from clinical isolates of Bacteroides species. (1992) (7)
Fosfomycin and fosmidomycin (2011) (7)
Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis (1984) (7)
Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin. (1988) (7)
FL1060: a new beta-lactam antibiotic withnovel properties (1973) (7)
In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin. (1978) (6)
Action and interaction of penicillin and gentamicin on enterococci. (1979) (6)
Antibiotic effects in vitro and the prediction of clinical response. (1997) (6)
Interactions between antibacterial agents of the quinolone group and nitrofurantoin. (1988) (6)
TREATMENT OF ACUTE BACTERIAL CYSTITIS: ECONOMY VERSUS EFFICACY (1980) (6)
In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria (1982) (6)
The scientific basis of antimicrobial chemotherapy : Thirty-eighth Symposium of the Society for General Microbiology, held at the University of Nottingham Medical School, September 1985 (1985) (6)
The Microbiological and Pharmacokinetic Profile of an Antibacterial Agent Useful for the Single-Dose Therapy of Urinary Tract Infection (1987) (6)
Effect of growth conditions and storage on the specific activity of beta-lactamases of Bacteroides spp. (1990) (5)
Use of an in Vitro Model of the Urinary Bladder in the Investigation of Bacterial Response to Antibiotics (1976) (5)
The responses of Escherichia coli to nalidixic acid. (1978) (5)
Characterization of β-Lactamases ofPrevotellaspecies (1996) (5)
Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem. (1987) (5)
Enterococcus faecalis exposed to daptomycin (4)
Changes in β-lactam antibiotic susceptibility and β-lactamase production of clinical isolates of Bacleroides and Prevotella species over a 9 year period (1996) (4)
The Alteration of Microbial Growth Curves by Antibiotics (1985) (4)
β-Lactam antibiotics (2010) (4)
What's the use of susceptibility testing? (1997) (4)
Comparison of the response ofEscherichia coli to fosfomycin and fosmidomycin (1987) (4)
Antimicrobial susceptibility testing: are we wasting our time? (1993) (4)
Factors affecting antibiotic concentrations in bladder urine. (1980) (4)
Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group. (1984) (4)
The antibacterial activity of Rowatinex. (1982) (4)
Comparative InVitro Activities ofCefotaxime andCeftizoxime (FK749): NewCephalosporins withExceptional Potency (1980) (4)
Correlations Between Methods for the Measurement of Antibiotic Synergy (1981) (3)
Changes in beta-lactam antibiotic susceptibility and beta-lactamase production of clinical isolates of Bacteroides and Prevotella species over a 9 year period. (1996) (3)
Comparative susceptibility of cefminox and cefoxitin to beta-lactamases of Bacteroides spp. (1991) (3)
The effect of zinc ions on the activity of metallo-beta-lactamases of Bacteroides fragilis. (1997) (3)
Letter: Co-trimoxazole and cephalexin in urinary tract infection. (1976) (3)
Antibiotic resistance in enterococci in Nottingham. (1990) (3)
The comparative activity of fosfomycin trometamol against organisms isolated from infected urines (2005) (3)
An in vitro model for assessing optimum antibiotic dosage in urinary tract infection (2005) (3)
The influence of anaerobiosis on the activity of fosfomycin trometamol (2005) (3)
In vitro activity of cefotaxime (1979) (2)
Turbidimetric response of Staphylococcus aureus and Enterococcus faecalis to daptomycin. (1988) (2)
Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests? (1996) (2)
The influence of chlorine and sulphonate substituents on the visible absorption maxima of some azo dyes (1986) (2)
CHAPTER 13 – β-Lactam antibiotics: cephalosporins (2010) (2)
Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis (1987) (2)
Comparative stability of meropenem against beta-lactamases from Bacteroides spp. (1993) (2)
An overview of the response of bacteria to beta-lactam antibiotics. (1986) (2)
Comparative Stability of Meropenem against β-Lactamases from Bacteroides spp. (1993) (2)
Phenotypic variability and sensitivity tests: carry on regardless. (1991) (2)
Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens. (1974) (2)
Biochemistry and Molecular Biology of Antimicrobial Drug Action, 5th edition (2001) (2)
Laboratory evaluation of pirbenicillin, a new penicillin with antipseudomonal activity. (1977) (2)
The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder. (1977) (2)
The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis. (1984) (2)
The other GMP: good manufacturing practice and its importance in the validation of constructed pharmaceutical facilities (2005) (2)
The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis. (1978) (2)
hydrolyse cefoxitin, latamoxef and imipenem (1986) (2)
Characterization of beta-lactamases in clinical isolates of Bacteroides. (1986) (2)
Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. (1975) (2)
63 – Helminths: Intestinal worm infections; filariasis; schistosomiasis; hydatid disease (2012) (2)
InVitro Activity ofCeftizoxime Against Bacteroides fragilis: Comparison withBenzylpenicillin , Cephalothin, andCefoxitin (1981) (2)
6 – TRIMETHOPRIM PLUS SULPHAMETHOXAZOLE: SYNERGIC OR ANTAGONISTIC COMBINATION? (1977) (2)
62 – Protozoa: Malaria; toxoplasmosis; cryptosporidiosis; amoebiasis; trypanosomiasis; leishmaniasis; giardiasis; trichomoniasis (2012) (1)
Resistance categories of enterobacteria to beta-lactam antibiotics. (1975) (1)
Antibacterial agents: susceptibility In Vitro and In Vivo (2001) (1)
Turbidimetric study of the effect of inoculum density on the response of Escherichia coli to gentamicin under aerobic and anaerobic conditions. (1991) (1)
The Influence of Chlorine and Sulphonate Substituents on the Visible Absorption Maxima of Some Azo Dyes. (1986) (1)
Variety in the response of Escherichia coli to erythromycin. (1972) (1)
Turbidimetric response ofStaphylococcus aureus andEnterococcus faecalis to daptomycin (1988) (1)
Strain variation in the response of Pseudomonas aeruginosa to carbenicillin. (1980) (1)
Lords a-leaping: the Soulsby report on antimicrobial drug resistance. (1998) (1)
Prophylactic vancomycin in very-low-birthweight infants (1992) (1)
Additional characteristics of Bacteroides fragilis carbapenemases belonging to group 3a (1997) (1)
Response of escherichia coli to beta-lactam antibiotics: Effect of the concomitant presence of staphylococci exhibiting inducible beta-lactamase activity (2005) (1)
Relationship of beta-lactamase production to growth phase inBacteroides species (1985) (1)
History of Antimalarial Agents (2003) (1)
The in vitro activity of ceftezol (demethylcefazolin) against dense populations of Escherichia coli. (1976) (1)
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli. (1981) (1)
United States Patent ( 19 ) Greenwood et al . ( 54 ) ANIONIC DYE HAVING HIGH WATER-FASTNESS (2017) (0)
Activity of the Trometamol Salt of Fosfomycin in the Treatment of Bacterial Cystitis an In vitro Model of (1986) (0)
Osmotic effects in sensitivity tests using beta-lactam antibiotics. (1978) (0)
Gentamicin assay in the presence of imipenem. (1986) (0)
S c a n n i n g e I ec t r o n m i c r osc o p y of Staph yo co ccus aureus and Enterococcus faecalis exposed to daptomycin (1989) (0)
Assessment of Susceptibility of Ampicillin-Resistant Enterobacteria to Cephalosporins (1975) (0)
Newer Antibiotics Active Against Bacteroides Fragilis: Comparison with Older Agents (1987) (0)
RATIONAL CHOICE OF ANTIBIOTIC (1976) (0)
Strategies for counteracting resistance to antibacterial agents. (1986) (0)
A micro-chamber for continuous microscopic monitoring of anaerobic bacteria. (1985) (0)
The clinical laboratory as an aid in chemotherapy of infectious disease (1978) (0)
Prospects for New Antibiotics: Keeping One Step Ahead (1985) (0)
The comparative activity of fosfomycin against organisms isolated from infected urines (1992) (0)
Monitoring treatment with aminoglycoside antibiotics. (1993) (0)
Studies on the emergence of resistance to lomefloxacin in vitro (1989) (0)
Simulating Those of the Urinary Bladder (1970) (0)
Magic Bullets, Lost Horizons. The Rise and Fall of Antibiotics S. G. B. Amyes. Taylor & Francis, London, UK, 2001. ISBN 0-415-27203-3. 262 pp. (2002) (0)
Action andinteraction ofpenicillin andgentamicin on enterococci (1979) (0)
Protective effect of Bacteroides fragilis metallo-β-lactamases on the susceptibility of co-pathogens to carbapenems in vitro (1997) (0)
Penicillin and the site of wall growth in Gram-negative bacilli (1973) (0)
Osmotic effects in sensitivity tests using β-lactam antibiotics (1978) (0)
Fosfomycin Trometamol: A Microbiological Evaluation (1988) (0)
Tolerance topenicillin instreptococci ofviridans group (1989) (0)
Lois N. Magner, A History of Infectious Diseases and the Microbial World (2010) (0)
MECILLINAM (1976) (0)
Trivial pursuits: a game microbiologists play (1987) (0)
A Practical Guide to Clinical Bacteriology (1995) (0)
The pros and cons of beta-lactam antibiotics: Profusion and confusion (1982) (0)
In vitro activity of cefotaxine. (1979) (0)

This paper list is powered by the following services:

David Greenwood's Academic­Influence.com Rankings

David Greenwood's Degrees

Why Is David Greenwood Influential?

David Greenwood's Published Works

Published Works

David Greenwood's AcademicInfluence.com Rankings